OVER KİSTİ NEDENİ İLE OPERE EDİLEN HASTALARIN DEĞERLENDİRİLMESİ: RETROSPEKTİF ANALİZ

Yıl 2016, Cilt: 6 Sayı: 1, 11 - 15, 19.10.2016

Hatice Yılmaz Doğru Asker Zeki Özsoy Akgul Arici Selim Gulucu Fazlı Demirtürk

https://doi.org/10.16899/ctd.15369

Öz

Amaç: 

Over kisti, bütün yaş grubundaki kadınlarda görülebilen yaygın bir jinekolojik problemdir. Bu çalışmada; over kisti nedeni ile opere edilen olguların klinik özelliklerini retrospektif olarak değerlendirmek amaçlanmıştır.

Gereç ve Yöntem: 

Bu çalışmaya, Gaziosmanpaşa Üniversitesi, Tıp Fakültesi, Kadın Hastalıkları ve Doğum AD polikliniğine over kisti tanısı konulup sevk edilmiş hastalar ile herhangi bir şikayet ile polikliniğe başvurup over kisti tanısı konmuş 50 olgunun dosyaları retrospektif olarak taranarak dahil edildi.

Bulgular:

Hastaların yaş ortalaması 33.75±11.70 idi. En sık şikayetin %79 ile kasık ağrısı olduğu tespit edildi. Laparoskopik cerrahi geçiren olguların hastanede kalış süresi (3.62±0.57 gün), laparatomi geçirenlerden (5.48±2.58 gün) anlamlı olarak daha düşük idi (p < 0.001). Olguların %52.7’si non-neoplastik tümör iken % 47.3’ü neoplastik tümör idi. 

Sonuç: 

Adneksiyal kitlelerde fizik muayenenin cerrahi yöntem seçimini etkileyen temel etmenlerden en önemlisi olduğu kanaatindeyiz. 

 

Anahtar Kelimeler

Over kistleri, biyokimyasal tümor belirteçleri, histopatoloji

Kaynakça

• Hilger WS, Magrina JF, Magtibay PM. Laparoscopic management of the adnexal mass. Clin Obstet Gy- necol 2006;49(3):535–548 .
• Koonings PP, Campbell K, Mishell DR Jr, Grimes DA. Relative frequency of primary ovarian neoplasms: a 10-year review. Obstet Gynecol 1989;74(6):921-6.
• Finkler NJ, Benacerraf B, Lavin PT, et al. Comparasion of serum CA 125, Clinical Impression and Ultrasound in the Preoperative Evalution of Ovarian Mass. Obstet Gynecol 1988;72(4):659-64.
• Jacobs I, Oram D, Fairbanks J, et al. A risk of malig- nancy index incorporating CA-125, ultrasound and menopausal status or the accurate preoperative diagnosis of ovarian cancer. Br J Obstet Gynaecol 1990;97(10):922- 929.
• Tingulstad S, Hagen B, Skjeldestad F, et al. Evaluation of a risk of malignancy index based on serum CA- 125, ultrasound findings and menopausal status in the pre- operative diagnosis of pelvic masses. Br J Obstet Gy- naecol 1996;103(8):826-31.
• Tingulstad S, Hagen B, Skjeldestad FE, et al. The risk- of-malignancy index to evaluate potential ovarian can- cers in local hospitals. Obstet Gynecol 1999;93(3):448- 52.
• Yamamoto Y, Yamada R, Oguri H, et al. Comparison of four malignancy indices in the preoperative evalu- ation of patients with pelvic masses. Eur J Obs Gyn Reprod Biol 2009;144(2):163-7.
• 8- Kanthikar SN, Dravid NV, Deore PN, et al. Clinico- histopatological analysis of Neoplastic and Non-Ne- oplastic Lesions of the Ovary: A 3-Year Prospective Study Journal of Clinical and Diagnostic Research. 2014;8(8):FC04-FC07.
• Bast RC, Klug TL, St John E, et al. Aradioimmunas- say using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med 1983;309(15):883-7.
• Chou CY, Chang CH, Yao BL, et al. Color doppler ul- trasonography and serum CA125 the differentiation of benign and malignant ovarian tumors. J Clin Ultra- sound 1994;22(8):491-6.
• Niloff JM, Bast RC Jr, Schaetzl EM, Knapp RC. Predic- tive value of CA 125 antigen levels in second-look procedures for ovarian cancer. Am J Obstet Gynecol 1985;151(7):981-6.
• Schutter EM, Kenemans P, Sohn C, et al. Diagnos- tic value of pelvic examination , ultrasound ,and se- rum CA125 in postmenopausal women with a pelvic mass: an international multicenter study. Cancer 1994;74(4):1398-406.
• Medeiros LR, Rosa DD, da Rosa MI, et al. Accuracy of CA-125 in the diagnosis of ovarian tumors: A quantita- tive systematic review. Eur J Obstet Gynecol Reprod Biol 2009;142(2):99-105
• Wang J, Sharma A, Ghamande SA et al. Serum protein profile at remission can accurately assess therapeutic outcomes and survival for serous ovarian cancer. PLoS One 2013;8(11):e78393.
• Bast RC, Xu F, Yu Y, et al. CA125 the past and the fu- ture. Int J Biol Markers 1998;13(4):179-87.
• Kurjak A, Schulman H, Sosic A, et al. Transvaginal ultrasound, color flow and doppler wave form of the postmenopausal adnexal mass. Obstet Gynecol 1992;80(6):917-21.
• Alobaid A, Memon A, Alobaid S, et al. Laparoscopic management of huge ovarian cysts. Int J Gynecol Ob- stet 2013;2013:380854.
• Ou CS, Liu YH, Zabriskie V, et al. Alternate methods for laparoscopic management of adnexal masses greater than 10 cm in diameter. J Laparoendosc Adv Surg Tech 2001;11(3):125-32.
• Salem HA. Laparoscopic excision of large ovarian cysts. J Obstet Gynaecol Res 2002;28(6):290-4.
• Sagiv R, Golan A, Glezerman M. Laparoscopic manage- ment of extremely large ovarian cysts. Obstet Gynecol 2005;105(6):1319-22.
• Kreuzer GF, Parodowski T, Wurche KD, et al. Neoplastic or nonneoplastic ovarian cyst? The role of cytology. Acta Cytol 1995;39(5):882-6.
• Martinez-Onsurbe P, Villaespesa AP, Anquela JMS. As- piration cytology of 147 adnexal cysts with histologic correlation. Acta Cytol. 2001;45(6):941-7.
• Maharyan S. Clinicomorphological study of ovar- ian lesions. Journal of Chitwan Medical College 2013;3(6):17-24.
• Al-Fozan H, Tulandi T. Left lateral predisposition of endometriosis and endometrioma. Obstet Gynecol 2003;101(1):164-6.